Reverse Transcriptase Inhibitors: all 1,328 studies that test it
Page 10 of 14. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
- TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI UseCompletedNCT00225303Phase 2
- Combination of Efavirenz and Truvada - COMET StudyCompletedNCT00224458Phase 4
- Boosted Atazanavir and Truvada Given Once-Daily - BATON StudyCompletedNCT00224445Phase 4
- Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion LymphomaCompletedNCT00217503Phase 2
- Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVPCompletedNCT00204308Phase 2
- Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive PatientsStatus unknownNCT00199979Phase 3
- A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected PatientsStatus unknownNCT00199121Phase 4
- Prevention of Milk-Borne Transmission of HIV-1C in BotswanaCompletedNCT00197587Not applicable
- Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected AdultsCompletedNCT00196599Phase 2
- A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL StudyCompletedNCT00192634Phase 4
- Tenofovir in HIV/HBV CoinfectionCompletedNCT00192595Phase 4
- Effect of Age on the Renal Clearance of AdefovirWithdrawnNCT00187746Phase 4
- ATV/Ritonavir Nevirapine Interaction (USPAC)CompletedNCT00162149Phase 1
- Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.CompletedNCT00158821Phase 3
- Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.TerminatedNCT00158704Not applicable
- Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)CompletedNCT00158457Phase 3
- The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral RegimensCompletedNCT00152061Not applicable
- An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ SubjectsCompletedNCT00144261Phase 4
- A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic FunctionsCompletedNCT00144248Phase 4
- A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)CompletedNCT00144183Phase 3
- Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVCompletedNCT00144157Phase 4
- 3TC or No 3TC for HIV With 3TC ResistanceSuspendedNCT00143728Phase 4
- D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)CompletedNCT00143702Phase 2/3
- NRTI-Sparing Pilot StudyCompletedNCT00143689Phase 4
- One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose NevirapineCompletedNCT00142337Phase 2
- Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
- Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily RegimenCompletedNCT00135369Phase 3
- Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
- Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
- 2NN & CHARM Long-Term Follow-up StudyCompletedNCT00127972Phase 4
- Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-InfectionCompletedNCT00127959Phase 4
- An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
- Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected PatientsTerminatedNCT00122577Phase 2
- Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)CompletedNCT00122538Phase 2
- Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIVTerminatedNCT00122512Phase 2
- Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIVCompletedNCT00122486Phase 2
- A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected SubjectsWithdrawnNCT00121017Phase 2
- Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in HaitiCompletedNCT00120510Not applicable
- Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their BabiesCompletedNCT00120471Phase 1
- Pediatric Nevirapine Resistance StudyStatus unknownNCT00117728Phase 3
- Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)CompletedNCT00116298Phase 3
- DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral TherapyCompletedNCT00116116Phase 4
- Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV TransmissionCompletedNCT00115648Phase 3
- Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)CompletedNCT00115609Phase 3
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
- Safety and Acceptability of a Vaginal MicrobicideCompletedNCT00111943Phase 2
- TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 TrialCompletedNCT00111280Phase 2
- Botswana Tenofovir Oral HIV Prophylaxis TrialTerminatedNCT00111150Phase 2/3
- Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyCompletedNCT00109603Not applicable
- Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 PatientsCompletedNCT00106379Phase 4
- GW873140 In Combination With Combivir In HIV Infected SubjectsTerminatedNCT00104429Phase 2
- Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, ChinaCompletedNCT00100594Not applicable
- Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in SenegalCompletedNCT00100568Not applicable
- ARQ 501 in Combination With Docetaxel in Patients With CancerCompletedNCT00099190Phase 1
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Blood Levels of Abacavir in HIV Infected AdolescentsCompletedNCT00087945Not applicable
- Three Month Course of Anti-HIV Medications for People Recently Infected With HIVWithdrawnNCT00087464Not applicable
- Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
- KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
- A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVCompletedNCT00082394Phase 4
- TMC125-C223: TMC125 in HIV-1 Infected SubjectsCompletedNCT00081978Phase 2
- Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
- Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsCompletedNCT00076791Phase 1
- ARQ 501 in Subjects With CancerCompletedNCT00075933Phase 1
- A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected SubjectsCompletedNCT00075231Phase 2
- Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIVCompletedNCT00074399Phase 3
- A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior TherapyCompletedNCT00053638Phase 3
- Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral RegimensCompletedNCT00052117Phase 2
- Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing RegimenCompletedNCT00051844Phase 2
- Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable
- Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
- Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive PatientsCompletedNCT00050895Phase 3
- A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced PatientsCompletedNCT00046176Phase 3
- Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve SubjectsCompletedNCT00043966Phase 3
- Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected SubjectsCompletedNCT00043953Phase 2
- Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIRCompletedNCT00043888Phase 3
- A Study of DPC 817 in HIV-Infected MalesCompletedNCT00040274Phase 1
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.TerminatedNCT00040157Phase 2
- Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAARTCompletedNCT00038532Phase 2
- Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic FailureCompletedNCT00038506Phase 4
- Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected PatientsCompletedNCT00038220Phase 2
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.TerminatedNCT00037622Not applicable
- Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus InfectionCompletedNCT00034359Phase 2
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
- Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected PeopleCompletedNCT00028366Not applicable
- Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA GelCompletedNCT00028132Phase 1
- Tenofovir Disoproxil Fumarate to Treat Pediatric HIVCompletedNCT00024986Phase 1
- TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily EfavirenzCompletedNCT00023413Phase 2
- Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and FibrosisWithdrawnNCT00023218Not applicable
- Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
- Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV TreatmentWithdrawnNCT00021489Phase 2
- Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIVStatus unknownNCT00017992Phase 2
- The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering DrugsCompletedNCT00017758Phase 1
- Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00016588Not applicable
- Zidovudine and Lamivudine Given Once Versus Twice DailyCompletedNCT00014014Phase 1
- A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-LamivudineCompletedNCT00013897Phase 3
- Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected PatientsCompletedNCT00013702Phase 2
- Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsStatus unknownNCT00011895Phase 4
- Blood Levels of Abacavir After One Dose in HIV-Infected Children and AdolescentsCompletedNCT00011479Phase 1